Stallion India Fluorochemicals IPO Subscription and GMP : The Initial Public Offer (IPO) of Stallion India Fluorochemicals Limited has received an excellent response from investors. This IPO has been subscribed about 186 times till 4 pm on its last day on 20 January 2025. There is a lot of craze regarding this IPO in the gray market also. GMP is indicating that the company’s stock can give high returns on listing. This IPO was open for subscription on 16 January 2025. Investors are hoping to take advantage of the company’s potential through this IPO.
This IPO of Stallion India Fluorochemicals is a mix of fresh issue and offer for sale (OFS). The size of the IPO is Rs 199.45 crore. The allotment of shares under the IPO will take place on January 21, while the shares will be transferred to the demat accounts of investors on January 22. Listing of this company on NSE and BSE is proposed on 23 January 2025.
High Return: 5 toppers of midcap mutual funds, investors’ money increased 3 to 4 times in 5 years, returns up to 39% on SIP
Stallion India IPO Subscription: 186 times
The IPO of Stallion India Fluorochemicals has received tremendous response from investors. This IPO has been subscribed about 186 times till 4 pm on its third and last day. 35 percent share is reserved for retail investors in the IPO and it has been subscribed about 92 times so far. 50 percent of the IPO is reserved for qualified institutional buyers and it has been subscribed around 173 times so far. Whereas 15 percent share is reserved for non-institutional investors and till now it has been subscribed 420.78 times.
NFO: Baroda BNP Paribas Mutual Fund launches Energy Opportunities Fund, what is the specialty of this scheme and who should invest?
Stallion India IPO GMP Status
There is a lot of craze in the gray market regarding the IPO of Stallion India Fluorochemicals. The unlisted stock of the company is at a premium of Rs 45 in the gray market. In terms of upper price band Rs 90, this premium is 50 percent. If this trade continues then the stock may be listed at Rs 135 as compared to the issue price of Rs 90.
Stallion India’s business model
Stallion India Fluorochemicals is primarily engaged in the business of refrigerants and industrial gases. The company manufactures gases through debulking, blending and processing. Apart from this, the company also sells pre-filled cans and small cylinders.
The company has four manufacturing units located in Maharashtra, Rajasthan and Haryana. All these facilities are designed to store gases in a safe environment. The company’s products are used in various sectors like air conditioners, refrigerators, fire safety, semiconductor manufacturing, automobiles, pharma and medicals.
SIP Topper: This midcap mutual fund became number 1 in 5 years and 10 years, SIP people got the highest returns
Stallion India Fluorochemicals has 20 years of experience in the refrigerant gas segment, making it a reputed brand. Competitive pricing, better service and high quality have a big role in the company’s growth. The company has a good reputation in terms of timely delivery and quality control.
SIP Return: This scheme of HDFC Mutual Fund made SIP of Rs 2000 Rs 4 crore, included in top 3 in terms of AUM.
Potential Risk Factors and Competition
More than 80% of the company’s income comes from the sale of refrigerant gases, so reduction in demand or changes in policy can affect the company’s income. Apart from this, most of the company’s business is dependent on Maharashtra and Delhi, due to which the regional risk increases. Since the raw material is supplied from China, the global situation may also impact the company’s business. Stallion India Fluorochemicals’ main competitors include SRF Limited, Gujarat Fluorochemicals Limited and Naveen Fluorine International Limited.
(Disclaimer: The purpose of this article is only to provide information, not to recommend investment. Take any investment decision only after taking the advice of your investment advisor.)
